Related Experiment Video
Updated: Apr 17, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Overexpression of phosphorylated 4E-binding protein 1 and its clinicopathological significances in gastric cancer
Hyoun Wook Lee1, Moon-Il Park1, Mee-Seon Kim1
1Department of Pathology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea.
Abstract:
Multiple intracellular transforming signals regulate eukaryotic translation initiation factor 4E (eIF4E)-binding protein (4E-BP1). The signals result in hierarchical phosphorylation of 4E-BP1, resulting in release of eIF4E, relieving translational repression and enhancing oncogenic protein synthesis. This study assessed the expression of phosphorylated 4E-BP1 (p-4E-BP1) in gastric cancer and its correlation with clinicopathological parameters and patient survival. Tissue microarray blocks were generated from 179 gastric carcinomas and immunohistochemically stained for p-4E-BP1. The expression of p-4E-BP1 was higher in tumors that were intestinal-type (P=0.028); had a diameter smaller than 5cm (P=0.001); were lower pathological T stage (P<0.001), N stage (P=0.004), or TNM stage (P<0.001); did not have distant metastasis (P=0.027). High p-4E-BP1 expression significantly correlated with prolonged overall survival (P=0.046) and disease-free survival (P=0.035), but was not an independent prognostic factor in multivariate analysis. Our results indicate that p-4E-BP1 is more highly expressed in early gastric cancers than in advanced ones, and has limited potential as an independent prognostic biomarker in patients with gastric cancer. Larger well-controlled studies with molecular validation are warranted to elucidate more exact prognostic significance and working mechanism of p-4E-BP1 in gastric cancer.
Insights
Phosphorylated 4E-binding protein 1 (p-4E-BP1) is more common in early gastric cancer. High p-4E-BP1 expression correlates with better survival but is not an independent prognostic factor.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Transforming signals regulate eukaryotic translation initiation factor 4E (eIF4E)-binding protein (4E-BP1) through phosphorylation.
- Phosphorylation of 4E-BP1 releases eIF4E, relieving translational repression and promoting oncogenic protein synthesis.
Purpose of the Study:
- To assess phosphorylated 4E-BP1 (p-4E-BP1) expression in gastric cancer.
- To correlate p-4E-BP1 expression with clinicopathological parameters and patient survival.
Main Methods:
- Generated tissue microarray blocks from 179 gastric carcinomas.
- Performed immunohistochemical staining for p-4E-BP1.
Main Results:
- p-4E-BP1 expression was higher in intestinal-type tumors, smaller tumors (<5cm), lower pathological T, N, and TNM stages, and in cases without distant metastasis.
- High p-4E-BP1 expression correlated with prolonged overall and disease-free survival.
- p-4E-BP1 was not an independent prognostic factor in multivariate analysis.
Conclusions:
- p-4E-BP1 is more highly expressed in early-stage gastric cancers.
- p-4E-BP1 has limited potential as an independent prognostic biomarker in gastric cancer.
- Further studies are needed to clarify the prognostic significance and mechanism of p-4E-BP1 in gastric cancer.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cell Specific Gene Expression

